Literature DB >> 21169841

Gout and hyperuricemia in young people.

Hisashi Yamanaka1.   

Abstract

PURPOSE OF REVIEW: Although gout and hyperuricemia have received considerable attention recently, there is limited information on the two conditions in young people. The molecular mechanisms of hyperuricemia have been investigated extensively in recent years, with this knowledge providing new insights and a better understanding of the precocious onset of gout and hyperuricemia. RECENT
FINDINGS: Serum uric acid levels are higher in the younger generation compared with the older generation. A proportion of gout and hyperuricemia in childhood is due to inborn errors in purine metabolism. Extensive investigation has demonstrated genetic polymorphisms in the urate transporter associated with hyperuricemia and gout. Whether or not polymorphisms affect the onset of gout and hyperuricemia in young people is unclear. Uric acid levels in childhood have also been shown to correlate with the development of the metabolic syndrome.
SUMMARY: Elevations in serum uric acid levels in childhood are often associated with other diseases and allied conditions. Hyperuricemia in young individuals is often a marker of the metabolic syndrome. Gout is not common in childhood compared with adulthood, and careful consideration of inborn errors of metabolism should be considered in these cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21169841     DOI: 10.1097/BOR.0b013e3283432d35

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  15 in total

1.  Juvenile gout: rare and aggressive.

Authors:  Celia Coelho Henriques; Agostinho Monteiro; Begoña Lopéz; Luís Sequeira; António Panarra; Nuno Riso
Journal:  BMJ Case Rep       Date:  2012-04-02

2.  Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample.

Authors:  Yunkyung Kim; Jihun Kang; Geun-Tae Kim
Journal:  Clin Rheumatol       Date:  2018-05-23       Impact factor: 2.980

Review 3.  The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects: a narrative review.

Authors:  G Zoppini; G Targher; E Bonora
Journal:  J Endocrinol Invest       Date:  2011-12       Impact factor: 4.256

4.  Design and Optimization of Febuxostat-loaded Nano Lipid Carriers Using Full Factorial Design.

Authors:  Shailendra Bhatt; Jai Bharti Sharma; Ruchi Kamboj; Manish Kumar; Vipin Saini; Shailendra Mandge
Journal:  Turk J Pharm Sci       Date:  2021-02-25

5.  Clinical characteristics of early- and late-onset gout: A cross-sectional observational study from a Chinese gout clinic.

Authors:  Bingqing Zhang; Weigang Fang; Xuejun Zeng; Yun Zhang; Ya Ma; Feng Sheng; Xinlei Zhang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China.

Authors:  Peige Song; He Wang; Wei Xia; Xinlei Chang; Manli Wang; Lin An
Journal:  Sci Rep       Date:  2018-03-12       Impact factor: 4.379

Review 7.  Biosensors Incorporating Bimetallic Nanoparticles.

Authors:  John Rick; Meng-Che Tsai; Bing Joe Hwang
Journal:  Nanomaterials (Basel)       Date:  2015-12-31       Impact factor: 5.076

Review 8.  Hyperuricemia in Children and Adolescents: Present Knowledge and Future Directions.

Authors:  Masaru Kubota
Journal:  J Nutr Metab       Date:  2019-05-02

9.  Clinical characteristics of patients under 40 years old with early-onset hyperuricaemia: a retrospective monocentric study in China.

Authors:  Yi Zhang; Yong Yang; Leixi Xue; Jian Wen; Lin Bo; Mei Tang; Ru Yang; Dong Yan; Zhichun Liu
Journal:  BMJ Open       Date:  2019-08-27       Impact factor: 2.692

10.  Serum Metabolic Profiling Analysis of Gout Patients Treated with Traditional Chinese Medicine Tongfengtai Granules Based on Gas Chromatography-Mass Spectrometry.

Authors:  Jianyong Zhang; Hong Pan; Jingjing Xie; Jing Wang; Ruyi Wang; Xia Qiu; Li Zhong; Tengyan Li; Yuya Xiao; Min Xiao; Yanying Zhang; Ertao Jia; Yubao Jiang; Binbin Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.